Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 29 tags : Fda save search
Tablo® Hemodialysis System Cartridge Receives FDA 510(k) Clearance Enabling Production in North America
Published: 2021-11-29 (Crawled : 23:00) - biospace.com/
OM | $2.04 -0.49% -0.49% 920K
|
Health Technology
|
| O: -0.04%
H: 1.02%
C: -4.97%
fda hemodialysis clearance
Adagene Announces FDA Clearance of IND for Phase 1b/2 Trial of Anti-CTLA-4 Monoclonal Antibody ADG116 in Combination Therapy with Anti-PD-1 Antibody PembrolizumabADG116-P001 trial being initiated at multiple sites with dosing to begin early 2022
Published: 2021-11-29 (Crawled : 23:00) - biospace.com/
ADAG | $2.6 -1.66% -0.36% 8.5K
|
Manufacturing
|
| O: 0.0%
H: 4.49%
C: -2.19%
fda clearance fda clearance phase 1 therapy antibody phase 1b trial initiated phase 2b
Caldolor® Now FDA Approved For Pre-Operative Administration
Published: 2021-11-29 (Crawled : 21:00) - prnewswire.com
CPIX | $1.55 -4.91% -4.49% 28
|
Health Technology
|
| O: 87.73%
H: 32.69%
C: 21.79%
fda
FDA Action Alert: Legend & Janssen, Merck & Ridgeback, Amryt, BeyondSpring an...
Published: 2021-11-29 (Crawled : 15:30) - biospace.com/
JNJ | $147.59 0.05% -0.18% 6.4M
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
fda
FDA Action Alert: Legend & Janssen, Merck & Ridgeback, Amryt, BeyondSpring and More
Published: 2021-11-29 (Crawled : 15:00) - biospace.com/
JNJ | $147.59 0.05% -0.18% 6.4M
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
fda
Avenue Therapeutics Announces FDA Advisory Committee Meeting to Review IV Tramadol NDA Tentatively Scheduled for February 15, 2022
Published: 2021-11-29 (Crawled : 15:00) - biospace.com/
ATXI | $0.125 -7.75% -12.82% 2.3M
|
Health Technology
|
| O: 8.11%
H: 49.17%
C: 41.67%
fda tentative therapeutics
Celularity Announces FDA Clearance of Investigational New Drug Application (IND) for Natural Killer Cell Therapy CYNK-101 in First-line Advanced Her2/neu Positive Gastric and Gastroesophageal Junction Cancer
Published: 2021-11-29 (Crawled : 14:30) - biospace.com/
CELU | $4.2 2.19% 5.3% 45K
|
|
| O: 1.48%
H: 2.19%
C: -2.19%
new drug fda clearance application drug fda clearance positive therapy cancer her2- her2
Viracta Therapeutics Announces Orphan Drug Designation Granted by FDA for its All-Oral Combination of Nanatinostat and Valganciclovir (Nana-val) for the Treatment of Epstein Barr Virus-Positive Diffuse Large B-cell Lymphoma
Published: 2021-11-29 (Crawled : 14:00) - biospace.com/
VIRX | $0.78 -32.17% -46.96% 600K
|
Manufacturing
|
| O: 3.57%
H: 4.21%
C: -12.45%
treatment fda drug granted therapeutics orphan drug positive t-cell designation
Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors
Published: 2021-11-29 (Crawled : 12:00) - biospace.com/
FENC | $10.5 -3.05% -3.14% 100K
|
Health Technology
|
| O: -50.05%
H: 0.0%
C: 0.0%
new drug fda solid tumors application drug
QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS
Published: 2021-11-29 (Crawled : 08:00) - biospace.com/
QGEN | $39.67 -1.27% 0.0% 550K
|
Health Technology
|
| O: -4.74%
H: 1.86%
C: 1.05%
QGEN | $39.67 -1.27% 0.0% 550K
|
Health Technology
|
| O: -4.74%
H: 1.86%
C: 1.05%
quantiferon fda fda approval test approval
Gainers vs Losers
| 45% | 55% |
Top 10 Gainers
DYNT | $0.3704 -5.27% 43.09% 5.5M
|
Health Technology
BRTX | $1.32 -1.49% 20.71% 3.3M
|
Professional, Scientific, and T...
PTN | $1.82 -5.21% 15.38% 290K
|
Health Technology
VIAO | $0.308 -26.67% 12.01% 390K
|
Electronic Technology
HNRA | $2.36 -9.58% 11.86% 220K
|
n/a
HYLN 4 | $1.32 -7.04% 8.33% 800K
|
Producer Manufacturing
UMAC | $1.85 -2.12% 8.11% 6.1K
|
BQ | $0.2429 -6.07% 6.63% 99K
|
Consumer Non-Durables
GORO F | $0.534 -0.6% 6.55% 630K
|
Non-Energy Minerals
LBRT 4 | $22.1 -1.6% 6.29% 2.1M
|
Industrial Services
Your saved searches
Save your searches and get alerts when important news are released.